Skip to main content

February's Psychedelic Capital Investigates Institutional Vs Retail Investor Impact

By: Issuewire
PYSCAP FEB 25TH

Attend the world’s premiere psychedelic due diligence conference exploring the clinical, research, and investment landscapes of the modern psychedelic renaissance.

Toronto, Ontario Feb 24, 2021 (Issuewire.com) - Microdose Psychedelic Insights ("Microdose"), a  leader in B2B psychedelic intelligence, to present in a partnership with The Conscious Fund the most active VC in psychedelic space, the next edition of Psychedelic Capital

#PsyCap is taking place on February 25h at 4:15 pm EST and will feature engaging presentations from MagicMed Industries, Algernon Pharmaceuticals Inc and Lobe Sciences

Details and schedule of the February PsyCap are as follows:

4:15 pm EST:  MagicMed Industries

   Featuring Dr. Joseph Tucker.

"We are pleased to present at the upcoming Psychedelic Capital conference focused on psychedelic investment insights. Our team continues to advance the creation and patenting of psychedelics-derivatives for MagicMed's molecular derivatives library, the Psybrary. We look forward to providing our current investor base and new potential shareholders with significant updates, including regarding our anticipated listing." - Dr. Joseph Tucker.

 

4:45 pm EST: Algernon Pharmaceuticals Inc

     Featuring Christopher Moreau, Cyndi Edwards, & David Nutt.

 

5:15 pm EST: Investment Banks

     Featuring Michael Astone, Michael Huttner, & Henri Sant-Cassia.

 

5:45 pm EST:  Lobe Sciences

     Featuring Phil Young & Maghsoud Dariani.

 

6:15 pm: Retail Investors

     Featuring Richard Skaife, Brandon Colwell, & Jeff Nielson.

 

Date:

February 25thth  2021 at 4:15 pm Eastern  

Registration site:

https://microdose.buzz/shop/psychedelic-capital/psychedelic-capital-feb-2021/

 

Concept:

Presentations are 30 minutes in length, with 10 minutes always allocated to a one-on-one Q&A session with the audience. Psychedelic Capital features the top companies, latest IPOs, newest opportunities, and deepest insights into the emerging psychedelic space. Live networking with all the attendees is available prior to and during the event. 

 

- ENDS - 

 

Notes to Editors 

To request media accreditation, or to arrange interviews with key personnel please contact:

Kristina Spionjak 

kristina@microdose.buzz

 

About Microdose Psychedelic Insights

Microdose Psychedelic Insights aims to unlock the potential of psychedelics through Industry events, market intelligence, original, evidence-based content, strategy, and community. We enable and empower society at large to make better, more mindful decisions about psychedelics and their intersection with healthcare, medicine, and personal growth. We work with the industry's most influential stakeholders, some of the world's best-known brands, and an unrivalled network of scientists, researchers, analysts, innovators, investors, and advisors. 

 

About PsyCap

This online event programming is dedicated to providing investment-grade information for the nascent psychedelic sector and presents a curated group of CEOs, financial experts, thought leaders, and investment luminaries from around the globe. Presentations are 30 minutes in length, with 10 minutes always allocated to a one-on-one Q&A session with the audience. Psychedelic Capital features the top companies, latest IPOs, newest opportunities, and deepest insights into the emerging psychedelic space. 

PYSCAP FEB 25THDavid NuttDr Joseph TuckerPhilip Young

Media Contact

Microdose Psychedelic Insights


*****@microdose.buzz

https://microdose.buzz

Source :Microdose Psychedelic Insights

This article was originally published by IssueWire. Read the original article here.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.